/
/
/

Supha Pharmachem Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Sep 2025Jun 2025Mar 2025
₹111 Cr₹113 Cr₹264 Cr
₹3 Cr₹3 Cr₹66 L
₹114 Cr₹117 Cr₹265 Cr
₹104 Cr₹111 Cr₹265 Cr
₹11 Cr₹5 Cr₹20 L
₹19 L-₹37 L₹2 Cr
₹10 Cr₹6 Cr-₹1 Cr
₹9 Cr₹5 Cr-₹2 Cr

Share Price Live Stats

Open (₹)0.28
Volume (₹)16.24 L
High (₹)0.28
Upper Circuit0.29
Low (₹)0.27
Lower Circuit0.27
Prev Close0.28
52W High (₹)1.80
Price0.28
52W Low (₹)0.25

Share Market Cap & Key Ratios Overview

M.Cap (₹)24.70 Cr
Div. Yield (%)0.00
PE Ratio11.60
Debt to Equity26.01
Price to Book1.67
Book Value0.76
EPS (TTM)0.02
Face Value1.00
ROE (%)4.85

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
ADANIENT-ANSE
PREMIERENE-ANSE
CPPLUS-ANSE
AEGISLOG-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
BLACKROSE-TNSE
SUPHA-ZNSE
LTP
1W Low
1W High
Market cap (₹)
2959.8+73.8 (2.56%)
2882.10
2967
3,97,859Cr
987.25-14.75 (-1.47%)
982.50
1009.85
44,919Cr
3824.4+75.85 (2.02%)
3647
3849
44,412Cr
1265.35-20.8 (-1.62%)
1235
1327.30
43,998Cr
373.6+1.2 (0.32%)
367.50
381.45
29,543Cr
475.8-1.65 (-0.35%)
464.95
494
15,273Cr
71.04-0.91 (-1.26%)
70.55
74.97
11,034Cr
345+1.5 (0.44%)
336.40
345.65
7,643Cr
506.45+4.6 (0.92%)
501.85
530.45
6,427Cr
112-0.2 (-0.18%)
110.05
115.90
565Cr
0.28+0 (0.00%)
0.26
0.28
25Cr

Key Highlights of Supha Pharmachem Ltd’s P&L

Depreciation was ₹3.87Lakh and finance costs were ₹7.64Cr in 2025-03-31